Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapyFRONTIERS IN IMMUNOLOGYIF5.92024-06-261OAAI
Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve RadiosensitivityPHARMACEUTICSIF5.52023-09-3019OAAI
Thiocarbonyl Derivatives of Natural Chlorins: Synthesis Using Lawesson's Reagent and a Study of Their PropertiesMOLECULESIF4.62023-05-201OAAI
Purification, physicochemical properties, and specificity of a ribonuclease produced by Trichoderma harzianumENZYME AND MICROBIAL TECHNOLOGYIF3.71996-02-019PREAI
未登录.png){kind=icon}
未登录
